Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
IPSC
#3010
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+6.42%
Variazione Mensile
-13.43%
Variazione di 6 mesi
+346.15%
Variazione Annuale
+256.92%
Chiusura Precedente
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
Volume
15
Mercati
Mercato Azionario Statunitense
Salute
IPSC
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
Dividend yield %
—
—
—
—
—
Payout ratio %
—
—
—
—
—
Notizie
TD Cowen avvia la copertura su Century Therapeutics con rating Buy
TD Cowen initiates Century Therapeutics stock rating at Buy
Clear Street ribadisce il rating Buy su Century Therapeutics a $6,60
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Clear Street riduce il target di prezzo delle azioni di Century Therapeutics a $6,60
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics ottiene 135 milioni di dollari in posizionamento privato
Century Therapeutics secures $135 million in private placement
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain